January 17, 2019
PledPharma to present its Phase III program for PledOx at CI Cancers Syposium
PledPharma will present its “first in class” drug candidate PledOx phase III program at the Gastrointestinal (GI) Cancers Symposium, taking place in San Francisco today and tomorrow.